- Home
- App Analytics
- Neo Rx - Autism ABA Therapy
- Neo Rx - Autism ABA Therapy Vs. Autism Care Therapy
Neo Rx - Autism ABA Therapy vs Autism Care Therapy Usage & Stats
Neo Rx has been designed to provide children with autism an individualized educational program by placing them on a learning sequence based on their performance assessment. This application can be used as an additive program or can also be used by those who do not have access to special education such as Autism Therapy. Deeply rooted in Autism Digital Therapy, this autism application uses ABA (Applied Behavior Analysis) principles to teach children skills using positive reinforcement and a positive learning setting. The child on the autism spectrum can access child-friendly videos, games, music, puzzles, and colouring on the application throughout their instruction. The individualized instruction is based on ABA principles and collects as well as graphs data on the child’s progress throughout the application to best guide the user. This application aims to increase independence skills in children and is designed to be a child-friendly learning app.
- Apple App Store
- Free
- Education
Store Rank
- -
ACT is an entertaining game for children with autism by engaging various stimuli (such as tapping to match cards, sorting objects into the right boxes, and answering simple questions) within a short time limit. It's designed to provide quick engaging challenges, improve cognitive skills, and improve their reaction times.
- Apple App Store
- Free
- Education
Store Rank
- -
Neo Rx - Autism ABA Therapy vs. Autism Care Therapy ranking comparison
Compare Neo Rx - Autism ABA Therapy ranking trend in the past 28 days vs. Autism Care Therapy
Rank
No Data Available
Neo Rx - Autism ABA Therapy vs. Autism Care Therapy ranking by country comparison
Compare Neo Rx - Autism ABA Therapy ranking trend in the past 28 days vs. Autism Care Therapy
No Data to Display
Compare to any site with our free trial
Neo Rx - Autism ABA Therapy VS.
Autism Care Therapy
December 19, 2024